Results 131 to 140 of about 5,403 (178)

Tau pathology in the brainstem monoaminergic neurons reflect resilience to Alzheimer's disease pathology in the Nun study cases. [PDF]

Acta Neuropathol Commun
Pezhouh MK, Chen G, Meints J, Hemmy LS, SantaCruz KS, Lee MK.   +5 more
europepmc   +1 more source

Cognitive Functioning in Phenylketonuria: A Lifespan Perspective. [PDF]

Nutrients
Huijbregts S, Romani C.
europepmc   +1 more source

Biogenic amines' residues in meat products with a reference to their microbial status. [PDF]

Open Vet J
Elgaffry O, Darwish WS, El Bayoumi RM, Hussein MA, Megahed A, Reda LM, Basiony A, Dawod YF.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Biogenic monoamine disorders

2016
Biogenic monoamine disorders are a group of inherited diseases characterized by a defect in the synthesis, transport, or degradation of catecholamines and serotonin. The phenotype mostly reflects the pattern and severity of the monoamine deficiency. Movement disorders due to cerebral dopamine deficiency are almost always prominent, mostly in the form ...
Roze, Emmanuel, Blau, Nenad
openaire   +3 more sources

Biogenic monoamines in Hirudo medicinalis

Histochemie, 1968
The distribution of certain catecholamines and indoleamines in the ventral nerve cord and the body segments of the medical leech, Hirudo medicinalis, was studied with the fluorescence microscope technique of Falck and Hillarp, with microspectrofluorometry, and with chemical determinations of the amines. The six cells of the segmental ganglia previously
B, Ehinger, B, Falck, H E, Myhrberg
openaire   +2 more sources

Biogenic monoamines in preimplantation development

Human Reproduction, 2011
The involvement of biogenic monoamines in early ('preneural') embryogenesis has been well documented in lower vertebrates, but much less information is available about the role of these molecules in the earliest stages of development in mammals, including humans.Databases (PubMed, ISI Web of Knowledge and Scopus) were searched for studies relating to ...
Stefan, Cikos, Dusan, Fabian, Alexander V, Makarevich, Peter, Chrenek, Juraj, Koppel   +4 more
openaire   +2 more sources

Age-related changes in brain biogenic monoamines and monoamine oxidase

General Pharmacology: The Vascular System, 1987
In experiments on 2-, 10- and 22-month old rats, it was found that essential age-related changes occurred in the brain level of biogenic monoamines (BMA) and in the monoamine oxidase (MAO) activity. In 22-month old rats the levels of dopamine (DA), noradrenaline (NA) and serotonin (5-HT) markedly declined in most of the brain structures studied.
V D, Petkov, S L, Stancheva, V V, Petkov, L G, Alova   +3 more
openaire   +2 more sources

Biogenic Monoamines in Early Embryos of Sea Urchins

Developmental Neuroscience, 1981
Indolylalkylamine determination was performed on the eggs and embryos of six species of sea urchins, using several fluorometric techniques, including the fluorescence of a substance itself and the fluorescence of its condensation products after treatment with orthophthaldialdehyde and ninhydrin.
B N, Manukhin, E V, Volina, L N, Markova, L, Rakic, G A, Buznikov   +4 more
openaire   +2 more sources

How are Biogenic Amines Metabolized by Monoamine Oxidases?

European Journal of Organic Chemistry, 2012
AbstractMonoamine oxidases (MAOs) are flavoenzymes important in regulating amine neurotransmitter levels and are the central pharmacological targets in treating depression and Parkinson's disease. On the basis of quantum chemical calculations, we have proposed a new two‐step hydride mechanism for the MAO‐catalysed oxidative deamination of amines.
Vianello, Robert, Repič, Matej, Mavri, Janez   +2 more
openaire   +3 more sources